하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
HIRONIC showcased its innovative products at the Aesthetic & Anti-Aging Medicine World Congress (AMWC), held in Monaco from the 27th to the 29th. The AMWC Congress is a pivotal event for professionals in dermatology and plastic surgery, offering a platform to share the latest in aesthetic and anti-aging medicine. Taking place at the Grimaldi Forum Monaco, this year's congress drew over 300 speakers, 15,000 attendees, and more than 900 leading companies, highlighting the newest advancements in anti-aging technologies and products.
During the congress, HIRONIC unveiled its latest range of skincare solutions, leveraging advanced technologies to set new standards in skin rejuvenation. Among the featured innovations were NEW DOUBLO™ 2.0 (V-RO ADVANCE™ in Korea), a cutting-edge skin lifting device that combines MFU and RF energies; GENTLO™ (SILKRO™), which integrates RF microneedling with PLASMA for enhanced treatment efficacy; and PICOHI™, a state-of-the-art picolaser device designed to deliver precise 300ps pulse durations for optimal results.
Reflecting on its participation, HIRONIC views the AMWC as a crucial stepping stone in demonstrating its leadership and innovative capabilities to the global market, with a special focus on Europe. The event served as an excellent opportunity for HIRONIC to introduce its proprietary technology to an international audience of medical professionals, paving the way for future growth. The company is optimistic about the impact of its participation, considering it a key moment for establishing new partnerships and further solidifying its market presence in the global aesthetic plastic surgery industry.
HIRONIC Press Center
